AusPAR: Ixekizumab
Related information
- Australian Public Assessment Reports for prescription medicines (AusPARs)
- Browse AusPARs by active ingredient
- Browse AusPARs by product name
- Browse AusPARs by sponsor
How to access a pdf or Word document
*Large file warning: Attempting to open large files over the Internet within the browser window may cause problems. It is strongly recommended you download this document to your own computer and open from there.
Australian Public Assessment Report
23 May 2017
| AusPAR | |
|---|---|
| Active Ingredient | Ixekizumab
|
| Product Name | Taltz
|
| Sponsor | Eli Lilly Australia Pty Ltd
|
| Submission Number | PM-2015-01878-1-4
|
| Submission Type | New chemical entity
|
| Decision | Approved
|
| AusPAR Date | 8 May 2017
|
| Publication Date | 23 May 2017 |